{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:54:41Z","timestamp":1781830481312,"version":"3.54.5"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anti\u2013N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is an autoimmune disorder characterized by antibodies against the NR1 subunit of the NMDA receptor. It predominantly affects young women and is frequently associated with ovarian teratomas. Early recognition, tumor removal, and immunotherapy are critical for favorable outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We report a 33-year-old woman with subacute headache, low-grade fever, generalized weakness, and mood disturbances, who developed generalized tonic\u2013clonic seizures and cognitive impairment. Brain MRI and CSF were initially normal, and EEG showed diffuse slowing without epileptiform discharges. Pelvic imaging revealed a large right ovarian mass. She was treated with corticosteroids, plasmapheresis, and ultimately rituximab, alongside right salpingo-oophorectomy. Histopathology confirmed an immature teratoma. Anti-NMDAR antibodies were later detected in CSF, confirming the diagnosis. Following tumor removal and immunotherapy, she achieved complete neurological recovery and remained seizure-free at six months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case highlights the diagnostic challenges of anti-NMDAR encephalitis, particularly when MRI and CSF are normal. Early tumor detection and removal, combined with prompt escalation to second-line immunotherapy when needed, are essential for favorable outcomes. Immature ovarian teratomas, although rare, can trigger severe disease and warrant careful evaluation in adult women presenting with acute neuropsychiatric symptoms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-026-04918-1","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:55:28Z","timestamp":1777614928000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic and therapeutic challenges in anti-NMDA receptor encephalitis associated with an ovarian immature teratoma"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8617-237X","authenticated-orcid":false,"given":"Mahmoud","family":"Doudein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherehan M.","family":"Doudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghad A.","family":"Lahlouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Omarya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"4918_CR1","unstructured":"Samanta D, Lui F. Anti-NMDAR Encephalitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026. [cited 2026 Mar 31]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551672\/. PubMed PMID: 31869136."},{"issue":"4","key":"4918_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391\u2013404. https:\/\/doi.org\/10.1016\/S1474-4422(15)00401-9 . PubMed PMID: 26906964; PubMed Central PMCID: PMC5066574.","journal-title":"Lancet Neurol"},{"issue":"9","key":"4918_CR3","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","volume":"378","author":"J Dalmau","year":"2018","unstructured":"Dalmau J, Graus F, Antibody-Mediated Encephalitis. N Engl J Med. 2018;378(9):840\u201351. 10.1056\/NEJMra1708712. PubMed PMID: 29490181.","journal-title":"N Engl J Med"},{"issue":"4","key":"4918_CR4","doi-asserted-by":"publisher","first-page":"350","DOI":"10.12701\/yujm.2020.00794","volume":"38","author":"J Lee","year":"2021","unstructured":"Lee J, Kang S, Chang HJ, Lee YH, Son JH, Kong TW, et al. Anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma in Korea: three case reports. Yeungnam Univ J Med. 2021;38(4):350\u20135. PubMed PMID: 33498105; PubMed Central PMCID: PMC8688789.","journal-title":"Yeungnam Univ J Med"},{"issue":"9","key":"4918_CR5","first-page":"573","volume":"115","author":"Y Malayev","year":"2015","unstructured":"Malayev Y, Alberts J, Verardi MA, Mattison AR, Imlay S. Immature Teratoma Associated With Anti-N-Methyl-D-Aspartate Receptor Encephalitis. J Am Osteopath Assoc. 2015;115(9):573\u20137. PubMed PMID: 26322937.","journal-title":"J Am Osteopath Assoc"},{"issue":"3","key":"4918_CR6","first-page":"436","volume":"76","author":"G Imataka","year":"2021","unstructured":"Imataka G, Yoshihara S. Immature ovarian teratoma with anti-NMDA-receptor encephalitis in a 13-year-old Japanese female patient. Med J Malaysia. 2021;76(3):436\u20137. PubMed PMID: 34031349.","journal-title":"Med J Malaysia"},{"key":"4918_CR7","doi-asserted-by":"publisher","first-page":"874867","DOI":"10.3389\/fneur.2022.874867","volume":"13","author":"H Zhang","year":"2022","unstructured":"Zhang H, Xiong W, Liu X, Liu W, Zhou D, Wu X. Long-Term Prognosis of Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis Who Underwent Teratoma Removal: An Observational Study. Front Neurol. 2022;13:874867. https:\/\/doi.org\/10.3389\/fneur.2022.874867 . PubMed PMID: 35493811; PubMed Central PMCID: PMC9039305.","journal-title":"Front Neurol"},{"key":"4918_CR8","doi-asserted-by":"publisher","unstructured":"Day GS, Laiq S, Tang-Wai DF, Munoz DG. Abnormal neurons in teratomas in NMDAR encephalitis. JAMA Neurol. 2014;71(6):717\u201324. https:\/\/doi.org\/10.1001\/jamaneurol.2014.488. PubMed PMID: 24781184.","DOI":"10.1001\/jamaneurol.2014.488"},{"issue":"5","key":"4918_CR9","doi-asserted-by":"publisher","first-page":"e8870","DOI":"10.1002\/ccr3.8870","volume":"12","author":"EM Khatrawi","year":"2024","unstructured":"Khatrawi EM, Prajjwal P, Marsool MDM, Das A, Nagre A, Inban P, et al. A case report of anti-NMDA receptor encephalitis in a 23-year-old female with acute psychiatric symptoms. Clin Case Rep. 2024;12(5):e8870. https:\/\/doi.org\/10.1002\/ccr3.8870 . PubMed PMID: 38721553; PubMed Central PMCID: PMC11077172.","journal-title":"Clin Case Rep"},{"key":"4918_CR10","doi-asserted-by":"publisher","first-page":"578850","DOI":"10.1016\/j.jneuroim.2025.578850","volume":"412","author":"K Simone","year":"2026","unstructured":"Simone K, Nathoo N, Hooper A, Aboseif A, Buletko AB, Satkunam N, et al. Immature ovarian teratomas in anti-NMDA receptor encephalitis. J Neuroimmunol. 2026;412:578850. https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578850.","journal-title":"J Neuroimmunol"},{"issue":"12","key":"4918_CR11","doi-asserted-by":"publisher","first-page":"e210109","DOI":"10.1212\/WNL.0000000000210109","volume":"103","author":"J Brenner","year":"2024","unstructured":"Brenner J, Ruhe CJ, Kulderij I, Bastiaansen AEM, Crijnen YS, Kret CN, et al. Long-Term Cognitive, Functional, and Patient-Reported Outcomes in Patients With Anti-NMDAR Encephalitis. Neurology. 2024;103(12):e210109. 10.1212\/WNL.0000000000210109. PubMed PMID: 39566012; PubMed Central PMCID: PMC11627176.","journal-title":"Neurology"},{"issue":"3","key":"4918_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1017\/S0033291719003283","volume":"51","author":"N Warren","year":"2021","unstructured":"Warren N, O\u2019Gorman C, McKeon G, Swayne A, Blum S, Siskind D. Psychiatric management of anti-NMDAR encephalitis: a cohort analysis. Psychol Med. 2021;51(3):435\u201340. PubMed PMID: 31739809.","journal-title":"Psychol Med"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04918-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04918-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04918-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:32:44Z","timestamp":1781829164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04918-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4918"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04918-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8590281\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for this case report according to the institutional policies of Istishari Arab Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of this case report and accompanying clinical details including imaging and labs results was obtained from the patient, who demonstrated good cognitive function at clinical follow-up at internal medicine clinic. In addition, written consent was also obtained from the patient\u2019s husband and father. All parties signed the consent form. A copy of the written consent is available for review by the Editor-in-Chief of this journal upon request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"401"}}